1. The apoptotic effect of Zoledronic acid on the nasopharyngeal carcinoma cells via ROS mediated chloride channel activation
   Liang Wang et al, 2018, Clinical and Experimental Pharmacology and Physiology CrossRef
2. The Effect of Everolimus in an In Vitro Model of Triple Negative Breast Cancer and Osteoclasts
   Laura Mercatali et al, 2016, International Journal of Molecular Sciences CrossRef
3. Physicochemical andin vitrocytotoxicity evaluation of polymeric drugs for combination cancer therapy
   Blessing Atim Aderibigbe et al, 2020, International Journal of Polymeric Materials and Polymeric Biomaterials CrossRef
4. Bone-seeking nanoplatform co-delivering cisplatin and zoledronate for synergistic therapy of breast cancer bone metastasis and bone resorption
   Yanjuan Huang et al, 2020, Acta Pharmaceutica Sinica B CrossRef
5. A Synergistic Combination of Niclosamide and Doxorubicin as an Efficacious Therapy for All Clinical Subtypes of Breast Cancer
   Garima Lohiya et al, 2021, Cancers CrossRef
6. The Antineoplastic Effect of Carboplatin Is Potentiated by Combination with Pitavastatin or Metformin in a Chemoresistant High-Grade Serous Carcinoma Cell Line
   Mariana Nunes et al, 2022, International Journal of Molecular Sciences CrossRef
7. Reactive Oxygen Species and Autophagy Associated Apoptosis and Limitation of Clonogenic Survival Induced by Zoledronic Acid in Salivary Adenoid Cystic Carcinoma Cell Line SACC-83
   Xi-Yuan Ge et al, 2014, PLoS ONE CrossRef
8. Synthesis, characterization and in vitro cytotoxicity evaluation of polyamidoamine conjugate containing pamidronate and platinum drug
   A.S. Ndamase et al, 2018, Journal of Drug Delivery Science and Technology CrossRef
9. Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model
   H Qiao et al, 2016, Cell Death & Disease CrossRef
10. Current State of Platinum Complexes for the Treatment of Advanced and Drug-Resistant Breast Cancers
    Bernhard Biersack et al, 2019, Breast Cancer Metastasis and Drug Resistance CrossRef
11. Crosstalk between bone niche and immune system: Osteoimmunology signaling as a potential target for cancer treatment
    Carmen Criscitiello et al, 2015, Cancer Treatment Reviews CrossRef
12. The Frequency of and Risk Factors for the Use of Bisphosphonates in the Adjuvant Setting of Primary Breast Cancer in Germany
    Eva-Maria Fick et al, 2015, Cancer Research and Treatment CrossRef
13. The miR-21/PTEN/Akt signaling pathway is involved in the anti-tumoral effects of zoledronic acid in human breast cancer cell lines
    M. Fragni et al, 2016, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
14. Combined Use of Zoledronic Acid Augments Ursolic Acid-Induced Apoptosis in Human Osteosarcoma Cells through Enhanced Oxidative Stress and Autophagy
    Chia-Chieh Wu et al, 2016, Molecules CrossRef
15. Improving reliability of live/dead cell counting through automated image mosaicing
    Filippo Piccinini et al, 2014, Computer Methods and Programs in Biomedicine CrossRef
16. Zoledronic acid targets chemo-resistant polyploid giant cancer cells
    Rezvan Adibi et al, 2023, Scientific Reports CrossRef
17. Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro
    Han Qiao et al, 2015, Acta Pharmacologica Sinica CrossRef
18. Management of bone metastasis with zoledronic acid: A systematic review and Bayesian network meta-analysis
    Justin-Pierre Lorange et al, 2023, Journal of Bone Oncology CrossRef
19. CSF-1 blockade impairs breast cancer osteoclastogenic potential in co-culture systems
    Chiara Liverani et al, 2014, Bone CrossRef